QR Kod

CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells

Development of the hybridoma technology by Köhler and Milstein (1975) has revolutionized the immunological field by enabling routine use of monoclonal antibodies (mAbs) in research and development efforts, resulting in their successful application in the clinic today. While recombinant good manufact...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Camille Le Gall, Felix Fennemann, Johan van der Schoot, Ferenc Scheeren, Martijn Verdoes
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bio-protocol LLC 2023-02-01
Seri Bilgileri:Bio-Protocol
Online Erişim:https://bio-protocol.org/en/bpdetail?id=4613&type=0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!